Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $23.4 billion.

  • Bristol Myers Squibb's Total Current Liabilities fell 150.16% to $23.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $23.4 billion, marking a year-over-year decrease of 150.16%. This contributed to the annual value of $23.4 billion for FY2025, which is 150.16% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Total Current Liabilities of $23.4 billion as of Q4 2025, which was down 150.16% from $28.1 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Total Current Liabilities ranged from a high of $28.1 billion in Q3 2025 and a low of $17.3 billion during Q1 2021
  • Its 5-year average for Total Current Liabilities is $22.4 billion, with a median of $22.5 billion in 2023.
  • In the last 5 years, Bristol Myers Squibb's Total Current Liabilities plummeted by 1891.46% in 2021 and then soared by 3530.0% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Total Current Liabilities (Quarter) stood at $21.9 billion in 2021, then grew by 0.1% to $21.9 billion in 2022, then grew by 1.7% to $22.3 billion in 2023, then rose by 6.79% to $23.8 billion in 2024, then dropped by 1.5% to $23.4 billion in 2025.
  • Its Total Current Liabilities stands at $23.4 billion for Q4 2025, versus $28.1 billion for Q3 2025 and $27.5 billion for Q2 2025.